CAPLIN POINT LABORATORIES
Back to Income Statement
|
CAPLIN POINT LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹376 Cr | ₹300 Cr | ₹242 Cr | ₹21,501 Cr | ₹177 Cr |
What is the latest Consolidated Net Profit of CAPLIN POINT LABORATORIES ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹376 Cr |
Mar2023 | ₹300 Cr |
Mar2022 | ₹242 Cr |
Mar2021 | ₹21,501 Cr |
Mar2020 | ₹177 Cr |
How is Consolidated Net Profit of CAPLIN POINT LABORATORIES Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹376 Cr | 25.49 | |
Mar2023 | ₹300 Cr | 23.76 | |
Mar2022 | ₹242 Cr | -98.87 | |
Mar2021 | ₹21,501 Cr | 12,077.96 | |
Mar2020 | ₹177 Cr | - |
Compare Consolidated Net Profit of peers of CAPLIN POINT LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CAPLIN POINT LABORATORIES | ₹19,733.0 Cr | 0.2% | 13.4% | 84.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹446,684.0 Cr | 1% | 4.6% | 47.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,935.0 Cr | 1% | -3.2% | 59.3% | Stock Analytics | |
CIPLA | ₹121,639.0 Cr | -1.1% | -0.3% | 20.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹115,931.0 Cr | 2.2% | 12.1% | 21.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,876.4 Cr | -2.7% | 0.8% | 43.8% | Stock Analytics |
CAPLIN POINT LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CAPLIN POINT LABORATORIES | 0.2% |
13.4% |
84.1% |
SENSEX | -0.7% |
-1.6% |
11.1% |
You may also like the below Video Courses